RNAC logo

Cartesian Therapeutics (RNAC) Retained Earnings

Annual Retained Earnings

-$614.65 M
-$219.71 M-55.63%

31 December 2023

RNAC Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Retained Earnings

-$681.82 M
-$24.18 M-3.68%

01 September 2024

RNAC Quarterly Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RNAC Retained Earnings Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-55.6%-56.0%
3 y3 years-51.9%-54.1%
5 y5 years-119.2%-112.5%

RNAC Retained Earnings High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-55.6%at low-73.5%at low
5 y5 years-119.2%at low-112.5%at low
alltimeall time-632.8%at low-511.4%at low

Cartesian Therapeutics Retained Earnings History

DateAnnualQuarterly
Sept 2024
-
-$681.82 M(+3.7%)
June 2024
-
-$657.63 M(-2.1%)
Mar 2024
-
-$671.47 M(+9.2%)
Dec 2023
-$614.65 M(+55.6%)
-$614.65 M(+40.7%)
Sept 2023
-
-$436.99 M(+2.1%)
June 2023
-
-$427.99 M(+2.7%)
Mar 2023
-
-$416.60 M(+5.5%)
Dec 2022
-$394.94 M(-8.2%)
-
Dec 2022
-
-$394.94 M(-1.5%)
Sept 2022
-
-$400.83 M(+2.0%)
June 2022
-
-$392.94 M(-2.1%)
Mar 2022
-
-$401.54 M(-6.7%)
Dec 2021
-$430.32 M(+6.3%)
-$430.32 M(-2.8%)
Sept 2021
-
-$442.56 M(+4.2%)
June 2021
-
-$424.66 M(-1.1%)
Mar 2021
-
-$429.23 M(+6.1%)
Dec 2020
-$404.63 M
-$404.63 M(+4.0%)
Sept 2020
-
-$389.18 M(+2.6%)
June 2020
-
-$379.45 M(+6.8%)
DateAnnualQuarterly
Mar 2020
-
-$355.37 M(+5.8%)
Dec 2019
-$335.75 M(+19.7%)
-$335.75 M(+4.6%)
Sept 2019
-
-$320.87 M(+3.9%)
June 2019
-
-$308.87 M(+5.6%)
Mar 2019
-
-$292.48 M(+4.3%)
Dec 2018
-$280.40 M(+29.3%)
-$280.40 M(+6.6%)
Sept 2018
-
-$263.15 M(+6.5%)
June 2018
-
-$247.15 M(+8.2%)
Mar 2018
-
-$228.36 M(+5.3%)
Dec 2017
-$216.90 M(+43.1%)
-$216.90 M(+9.9%)
Sept 2017
-
-$197.35 M(+8.0%)
June 2017
-
-$182.68 M(+9.6%)
Mar 2017
-
-$166.71 M(+10.0%)
Dec 2016
-$151.58 M(+35.9%)
-$151.58 M(+10.2%)
Sept 2016
-
-$137.49 M(+6.0%)
June 2016
-
-$129.76 M(+7.2%)
Mar 2016
-
-$121.05 M(+8.6%)
Dec 2015
-$111.51 M(+32.9%)
-$111.51 M
Dec 2014
-$83.88 M
-

FAQ

  • What is Cartesian Therapeutics annual retained earnings?
  • What is the all time high annual retained earnings for Cartesian Therapeutics?
  • What is Cartesian Therapeutics annual retained earnings year-on-year change?
  • What is Cartesian Therapeutics quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Cartesian Therapeutics?
  • What is Cartesian Therapeutics quarterly retained earnings year-on-year change?

What is Cartesian Therapeutics annual retained earnings?

The current annual retained earnings of RNAC is -$614.65 M

What is the all time high annual retained earnings for Cartesian Therapeutics?

Cartesian Therapeutics all-time high annual retained earnings is -$83.88 M

What is Cartesian Therapeutics annual retained earnings year-on-year change?

Over the past year, RNAC annual retained earnings has changed by -$219.71 M (-55.63%)

What is Cartesian Therapeutics quarterly retained earnings?

The current quarterly retained earnings of RNAC is -$681.82 M

What is the all time high quarterly retained earnings for Cartesian Therapeutics?

Cartesian Therapeutics all-time high quarterly retained earnings is -$111.51 M

What is Cartesian Therapeutics quarterly retained earnings year-on-year change?

Over the past year, RNAC quarterly retained earnings has changed by -$244.83 M (-56.03%)